Endo Pharmaceuticals (ENDP +1.5%) gains after receiving FDA approval for its Felodipine...

|About: Endo International plc (ENDP)|By:, SA News Editor

Endo Pharmaceuticals (ENDP +1.5%) gains after receiving FDA approval for its Felodipine extended-release tablets, a generic version of AstraZeneca's (AZN +0.3%) Plendil blood pressure medication.